Cargando…

Correlation of SARS-CoV-2 Neutralization with Antibody Levels in Vaccinated Individuals

Neutralizing antibody titers are an important measurement of the effectiveness of vaccination against SARS-CoV-2. Our laboratory has set out to further verify the functionality of these antibodies by measuring the neutralization capacity of patient samples against infectious SARS-CoV-2. Samples from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chowdhury, Shazeda Haque, Riley, Sean, Mikolajczyk, Riley, Smith, Lauren, Suresh, Lakshmanan, Jacobs, Amy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057460/ https://www.ncbi.nlm.nih.gov/pubmed/36992501 http://dx.doi.org/10.3390/v15030793

Ejemplares similares

Point mutations in SARS-CoV-2 variants induce long-range dynamical perturbations in neutralizing antibodies
por: Ray, Dhiman, et al.
Publicado: (2022)

Correlation of SARS-CoV-2 Viral Neutralizing Antibody Titers with Anti-Spike Antibodies and ACE-2 Inhibition among Vaccinated Individuals
por: Grunau, Brian, et al.
Publicado: (2022)

Permissive omicron breakthrough infections in individuals with binding or neutralizing antibodies to ancestral SARS-CoV-2
por: Williams, Erin, et al.
Publicado: (2022)

Rapid determination of SARS-CoV-2 antibody neutralization titer using Bio-Rad Bio-Plex correlates strongly with pseudovirus-determined neutralization titer
por: Heaps, Amy L., et al.
Publicado: (2023)

Neutralizing Activity of SARS-CoV-2 Antibodies in Patients with COVID-19 and Vaccinated Individuals
por: Vilibic-Cavlek, Tatjana, et al.
Publicado: (2023)

Ancestral SARS-CoV-2-Driven Antibody Repertoire Diversity in an Unvaccinated Individual Correlates with Expanded Neutralization Breadth
por: Deshpande, Suprit, et al.
Publicado: (2023)

Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual
por: Seydoux, Emilie, et al.
Publicado: (2020)

Insights into neutralizing antibody responses in individuals exposed to SARS-CoV-2 in Chile
por: Beltrán-Pavez, Carolina, et al.
Publicado: (2021)

Evaluation and correlation between SARS-CoV-2 neutralizing and binding antibodies in convalescent and vaccinated subjects
por: Manenti, Alessandro, et al.
Publicado: (2022)

Multiplex assessment of SARS-CoV-2 antibodies improves assay sensitivity and correlation with neutralizing antibodies
por: Cook, Nathan, et al.
Publicado: (2021)

Antibody Binding to SARS-CoV-2 S Glycoprotein Correlates with but Does Not Predict Neutralization
por: Ding, Shilei, et al.
Publicado: (2020)

Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans
por: Vanshylla, Kanika, et al.
Publicado: (2021)

Assessment of neutralizing antibody responses after natural SARS-CoV-2 infection and vaccination in congolese individuals
por: Batchi-Bouyou, Armel Landry, et al.
Publicado: (2022)

Outliers Matter—Correlation between S1 IgG SARS-CoV-2 Antibodies and Neutralizing SARS-CoV-2 Antibodies
por: Hocher, Berthold, et al.
Publicado: (2022)

SARS-CoV-2 re-infection, vaccination and neutralizing antibodies
por: Bongiovanni, Marco, et al.
Publicado: (2022)

Sex disparities and neutralizing antibody durability to SARS-CoV-2 infection in convalescent individuals
por: Markmann, Alena J., et al.
Publicado: (2021)

Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals
por: Markmann, Alena J., et al.
Publicado: (2021)

Correlation of vaccine‐elicited antibody levels and neutralizing activities against SARS‐CoV‐2 and its variants
por: Liu, Jinbiao, et al.
Publicado: (2021)

Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants
por: Tran, Trung The, et al.
Publicado: (2022)

Postconvalescent SARS-CoV-2 IgG and Neutralizing Antibodies are Elevated in Individuals with Poor Metabolic Health
por: Racine-Brzostek, Sabrina E, et al.
Publicado: (2021)

Correlates of Neutralizing/SARS-CoV-2-S1-binding Antibody Response with Adverse Effects and Immune Kinetics in BNT162b2-Vaccinated Individuals
por: Maeda, Kenji, et al.
Publicado: (2021)

Correlates of neutralizing/SARS-CoV-2-S1-binding antibody response with adverse effects and immune kinetics in BNT162b2-vaccinated individuals
por: Maeda, Kenji, et al.
Publicado: (2021)

Antibody-mediated neutralization of SARS-CoV-2
por: Gruell, Henning, et al.
Publicado: (2022)

Neutralizing antibodies for SARS-CoV-2 infection
por: Berenguer, Juan
Publicado: (2022)

Clinical performances of an ELISA for SARS-CoV-2 antibody assay and correlation with neutralization activity
por: Padoan, Andrea, et al.
Publicado: (2020)

SARS-CoV-2 neutralizing antibody levels are correlated with severity of COVID-19 pneumonia
por: Chen, Wei, et al.
Publicado: (2020)

SARS-CoV-2-Neutralizing Antibody Response and Correlation of Two Serological Assays with Microneutralization
por: Souiri, Amal, et al.
Publicado: (2023)

Antibody responses to individual proteins of SARS coronavirus and their neutralization activities
por: Qiu, Maofeng, et al.
Publicado: (2005)

Lectin Fingerprinting Distinguishes Antibody Neutralization in SARS-CoV-2
por: Wuo, Michael G., et al.
Publicado: (2023)

Direct capture of neutralized RBD enables rapid point-of-care assessment of SARS-CoV-2 neutralizing antibody titer
por: Connelly, Guinevere G., et al.
Publicado: (2022)

Differential persistence of neutralizing antibody against SARS-CoV-2 in post immunized Bangladeshi population
por: Roy, Dipa, et al.
Publicado: (2022)

Anti-spike, Anti-nucleocapsid and Neutralizing Antibodies in SARS-CoV-2 Inpatients and Asymptomatic Individuals
por: Brochot, Etienne, et al.
Publicado: (2020)

Down‐regulation of SARS‐CoV‐2 neutralizing antibodies in vaccinated smokers
por: Zhang, Jiahui, et al.
Publicado: (2022)

W102 Correlation between the atellica SARS-COV-2 IGG assay results and the presence of SARS-COV-2 neutralizing antibodies
por: Bedini, J., et al.
Publicado: (2022)

Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizers
por: Rujas, Edurne, et al.
Publicado: (2021)

Disease Severity, Fever, Age, and Sex Correlate With SARS-CoV-2 Neutralizing Antibody Responses
por: Schlickeiser, Stephan, et al.
Publicado: (2021)

Salivary IgG to SARS-CoV-2 indicates seroconversion and correlates to serum neutralization in mRNA-vaccinated immunocompromised individuals
por: Healy, Katie, et al.
Publicado: (2022)

SARS-CoV-2 neutralizing antibody development strategies
por: BALCIOĞLU, Bertan Koray, et al.
Publicado: (2020)

Human antibodies can neutralize SARS-CoV-2
por: Catalan-Dibene, Jovani
Publicado: (2020)

Neutralizing antibody titres in SARS-CoV-2 infections
por: Lau, Eric H. Y., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hu1jfuq9kc2sgp90am3gujc9ev